Complementary and alternative medicine for the treatment of fibromyalgia by J. Langhorst et al.
Editorial
Complementary and Alternative Medicine
for the Treatment of Fibromyalgia
Jost Langhorst,1 Winfried Häuser,2,3 Romy Lauche,1 Serge Perrot,4
Cayetano Alegre,5 and Piercarlo C. Sarzi Puttini6
1 Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine,
University of Duisburg-Essen, 45276 Essen, Germany
2Department of Internal Medicine 1, Klinikum Saarbru¨cken, 66119 Saarbru¨cken, Germany
3Department of Psychosomatic Medicine and Psychotherapy, Technische Universita¨t Mu¨nchen, 81865 Mu¨nchen, Germany
4 Service de Me´decine Interne et The´rapeutique, Centre de la Douleur, Hoˆtel Dieu, Universite´ Paris Descartes,
INSERM U 987, Paris, France
5 Department of Rheumatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
6Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Correspondence should be addressed to Jost Langhorst; j.langhorst@kliniken-essen-mitte.de
Received 17 November 2013; Accepted 17 November 2013; Published 9 January 2014
Copyright © 2014 Jost Langhorst et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The fibromyalgia syndrome (FMS) is a chronic condition
characterized by chronic widespread pain, fatigue, cognitive
disturbances, sleep disorders, and somatic and psychological
distress [1, 2]. Between 2.9 and 3.8% of the general population
in Europe and the US are affected [3–5], with 9 times as many
women as men in clinical settings [2].
Many patients with fibromyalgia use complementary and
alternative therapies to cope with their disease. A recent con-
sumers report indicated that 67.0% of German FMS patients
used heat application or thermal baths, 35.2% different CAM
medications such as homeopathy, dietary supplements, and
vitamins, 34.6% some kind of diet, 28.5% tool-based physical
therapies such as acupuncture, and 18.4%meditative exercises
such as yoga or tai chi [6]. In summary, almost every
FMS patient had used at least one CAM therapy for the
management of FMS. In an Internet sample of US American
FMS patients, the frequencies were slightly higher [7]. CAM
use in FMS patients is associated with younger age, female
gender, and higher overall disease burden [8, 9].
Contrary to the frequent use, only limited research has
been conducted on complementary and alternative therapies
so far. Data on efficacy and safety are however necessary
to judge their value within the treatment regimen. Without
reliable information, such therapies that might benefit FMS
patients will also not be included in standard care; therapies
with a negative benefit-risk ratio on the other hand might be
applied despite doubts about their effects.
This special issue aimed to facilitate publication of
research of complementary and alternative therapies for the
fibromyalgia syndrome. The papers published in this special
issue were carefully selected to display a great variety of
different research topics. In the following, a short overview
of included papers will be provided.
M.-A. Fitzcharles et al. took a closer look at classification
and clinical diagnosis of the fibromyalgia syndrome. Three
evidence-based interdisciplinary guidelines from Canada,
Germany, and Israel were compared in terms of definition
and diagnostic procedures, and consistent results have been
found for all three guidelines. The results of this review
further implied the importance of evidence-based guidelines
for health care providers. J. N. Ablin et al. summarized the
recommendations of those guidelines with a special emphasis
on CAM therapies. While all guidelines supported patient-
tailored approaches, recommendations differed, especially
regarding CAM. Discrepancies were also present regarding
the levels of evidence and the strengths of recommendation.
Contrary to Germany and Israel, where some CAM therapies
were recommended, no CAM treatment was recommended
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according to the Canadian guidelines.This supports the need
for high-quality research.
Three papers reported on clinical trials. In the so-called
KAFA-trial, C. S. Kessler et al. investigated the feasibility
and efficacy of an additive complex Ayurvedic treatment in
32 FMS patients, using a nonrandomized controlled study
design. All patients received conventional care during an
inpatient hospital admission with elements of physiotherapy,
hydrotherapy, exercise, and cognitive behavioral and occu-
pational therapies. The Ayurvedic group also received indi-
vidual treatment regimen including massages, diets, yoga,
and self-help strategies. At the end of two weeks, different
parameters including quality of life, pain, and sleep quality
were assessed. A prospective observational trial by K. Kraft
et al. with 70 patients tested the effects of vibration massage
using a deep oscillation device. Patients were treated twice
weekly for five weeks and followed up for two months.
Outcomes included safety and tolerability, symptom severity,
and quality of life. Finally, J. Sawynok et al. reported the
results of an extension trial that investigated 20 FMS patients
who had been included in a trial on the effects of qigong for
six months. Outcomes included quantitative measures such
as pain intensity, disability and quality of life, and qualitative
comments of participants.
Another fourmanuscripts reported the results of reviews;
one of them was a narrative review and three were sys-
tematic reviews, partially with meta-analyses. J. N. Ablin et
al. provided a qualitative-narrative review and a historical
perspective on the use of spa treatment for fibromyalgia. The
authors not only included clinical trials, but also publications
regarding the history, the implementation of spa therapy,
and related practices in different cultures and provided the
readers with a comprehensive overview. Another review by
S. S. Nascimento et al. systematically reviewed the efficacy
and safety of medicinal plants or related natural products
for fibromyalgia. Eight randomized controlled trials were
included in this analysis; possible benefits and harms were
investigated. R. Lauche et al. aimed to summarize the efficacy
and safety of qigong trials. Seven randomized controlled
trials with 395 were included and the authors analyzed
whether quality of life and other key symptoms were altered
by qigong interventions. An established tool to formulate
recommendation for clinical practice was also applied. And J.
A. Glombiewski et al. conducted a systematic review on EMG
andEEG-Biofeedback for FMS. Seven randomized controlled
trials were included based on 321 patients. Together these
reviews provide up to date information about the state of
scientific evidence for the respective topics.
The authors are confident that this special issue will pro-
vide readers with an insightful cross-section of current FMS
research topics and facilitate further high-quality research in
the CAM field for the sake of FMS patients.
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